DE:TG1N / Armata Pharmaceuticals, Inc. - Institutionelt ejerskab - Sælgere

Armata Pharmaceuticals, Inc.
DE ˙ DB ˙ US04216R1023
6,90 € ↑0,10 (1,47%)
2026-05-29
DEL PRIS
Institutionelt og fondsejerskab - Sælgere

Denne side viser institutioner, fonde og større aktionærer, der har reduceret beholdninger eller lukket deres positioner i deres seneste rapporteringsperiode. Røde rækker angiver lukkede positioner. Klik på linkikonet for at se den fulde transaktionshistorik.

Opgrader for at låse op for premium-data.

Fil dato Kilde Investor Type Gennemsnitlig pris
(Øst)
Aktier Δ Aktier
(%)
Rapporteret
Værdi
($1000)
Δ Værdi
(%)
Port Alloc
(%)
2026-02-11 13F Jpmorgan Chase & Co 0 -100,00 0
2026-05-15 13F Citadel Advisors Llc 0 -100,00 0
2026-05-15 13F 683 Capital Management, LLC 137.000 -2,04 1.403 59,68
2026-02-11 13F Group One Trading, L.p. 0 -100,00 0
2026-05-13 13F BlackRock, Inc. 65.050 -10,60 666 46,05
2026-05-14 13F Renaissance Technologies Llc 38.496 -43,80 394 -8,37
2026-05-12 13F Bnp Paribas Arbitrage, Sa 0 -100,00 0
2026-02-13 13F Barclays Plc 0 -100,00 0
2026-05-15 13F Tower Research Capital LLC (TRC) 277 -82,73 3 -80,00
2026-05-15 13F OMERS ADMINISTRATION Corp 0 -100,00 0
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
US:ARMP 7,59 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista